Article
Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy - 1 Apr 2004
Mariam Deneke H, Mengistu Yohannes, Hoffner Sven E, Andersson Dan I
Abstract excerpt
Rifampin is a major drug used in the treatment of tuberculosis infections, and increasing rifampin resistance represents a worldwide clinical problem. Resistance to rifampin is caused by mutations in the rpoB gene, encoding the beta-subunit of RNA polymerase. We examined the effect of three diffe...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
